menu
    • menu
    [{"orgOrder":0,"company":"Ziololek","sponsor":"Polpharma","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"POLAND","productType":"Other Small Molecule","year":"2024","type":"Acquisition","leadProduct":"Flaxseed","moa":"Undisclosed","graph1":"Dermatology","graph2":"Approved FDF","graph3":"Ziololek","amount2":0,"highestDevelopmentShortName":"","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ziololek \/ Polpharma","highestDevelopmentStatusID":"15","companyTruncated":"Ziololek \/ Polpharma"}]

    Find Clinical Drug Pipeline Developments & Deals for Flaxseed

    Menu

    Flaxseed

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Ziololek

                            Poland arrow
                            STLE Annual Meeting
                            Not Confirmed

                            Ziololek

                            Poland arrow
                            STLE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Flaxseed

                            Therapeutic Area : Dermatology

                            Study Phase : Approved FDF

                            Sponsor : Polpharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Polpharma Acquires Ziołolek

                            Details : Through the acquisition, Polpharma enhanced its portfolio of OTC & dermatology products, including Linomag (linseed oil), which is indicated for treating skin conditions such as eczema & intertrigo.

                            Product Name : Linomag

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            January 10, 2024

                            Lead Product(s) : Flaxseed

                            Therapeutic Area : Dermatology

                            Highest Development Status : Approved FDF

                            Sponsor : Polpharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth